|
Wed, 08/14/2024 - 06:45 |
Chugai Files Elevidys (SRP-9001) as a Gene Therapy Product for Duchenne Muscular Dystrophy in Japan |
Chugai |
|
Mon, 12/21/2020 - 05:57 |
Digging deep for differences in Duchenne muscular dystrophy |
UTSouthwestern |
|
Fri, 05/15/2020 - 14:14 |
Pfizers New Phase 1b Results of Gene Therapy in Ambulatory Boys with Duchenne Muscular Dystrophy (DMD) Support Advancement into Pivotal Phase 3 Study |
Pfizer |
|
Tue, 03/03/2020 - 05:26 |
Test will identify Duchenne muscular dystrophy and some other types of muscle conditions |
RTI International |
|
Mon, 01/27/2020 - 16:52 |
Gene scissors against incurable muscular disease |
Technical Unive... |
|
Fri, 12/13/2019 - 05:49 |
PerkinElmer Launches First FDA-Approved Assay Kit to Screen for Duchenne Muscular Dystrophy in Newborns |
PerkinElmer |
|
Thu, 12/12/2019 - 00:24 |
Sarepta Therapeutics Announces FDA Approval of VYONDYS 53 (golodirsen) Injection for the Treatment of Duchenne Muscular Dystrophy (DMD) in Patients Amenable to Skipping Exon 53 |
Sarepta |
|
Fri, 06/28/2019 - 11:03 |
Pfizer Presents Initial Clinical Data on Phase 1b Gene Therapy Study for Duchenne Muscular Dystrophy (DMD) |
Pfizer |
|
Thu, 06/06/2019 - 17:44 |
Nonprofit CureDuchenne is Encouraged to See Gene Editing for Duchenne Advance Through Vertexs Acquisition of Exonics Therapeutics |
CureDuchenne |
|
Thu, 05/23/2019 - 07:12 |
Sarepta Therapeutics Statement on ICER Draft Evidence Report for Treatments for Duchenne Muscular Dystrophy |
Sarepta |
|
Thu, 04/25/2019 - 18:03 |
Scientists on cusp of solving genetic diseases by snipping defective DNA |
UTSouthwestern |
|
Wed, 03/06/2019 - 06:57 |
Scientists find method to boost CRISPR efficiency |
UTSouthwestern |
|
Thu, 12/20/2018 - 21:38 |
Federal Trade Commission Acts for First Time Against Stem Cell Clinics |
Pew Trusts |
|
Thu, 12/20/2018 - 03:42 |
Phase III OLYMPUS and ROCKIES trials for roxadustat met their primary endpoints in chronic kidney disease patients with anaemia |
AstraZeneca |
|
Mon, 12/17/2018 - 22:54 |
Roxadustat approved in China for the treatment of anaemia in chronic kidney disease patients on dialysis |
AstraZeneca |
|
Tue, 11/27/2018 - 14:53 |
Salk scientist Ronald Evans named 2018 AAAS Fellow |
Salk Institute |
|
Tue, 11/13/2018 - 17:08 |
500 Doctors Urge Texas A&M to End Canine Muscular Dystrophy Experiments |
PETA |
|
Tue, 11/13/2018 - 14:37 |
FDA warns StemGenex Biologic Laboratories LLC of illegally marketing an unapproved cellular product manufactured in a facility with significant manufacturing violations, putting patients at risk |
FDA |
|
Mon, 11/12/2018 - 10:45 |
Moths and magnets could save lives |
RiceUniv |
|
Mon, 11/12/2018 - 08:09 |
Precision Medicine Has Transformed Cancer Treatment. Heres How to Move It Beyond Oncology |
MMRF |
|
Sun, 11/04/2018 - 23:32 |
CureDuchenne and Avidity Biosciences Host Webinar on Pre-clinical Development of Novel Exon Skipping Therapies for Duchenne Muscular Dystrophy |
CureDuchenne |
|
Tue, 10/30/2018 - 08:51 |
Risking the unknown in hope of a cure: The ethics of patient access to experimental treatments |
Nuffield Bioethics |
|
Thu, 10/18/2018 - 12:47 |
Juan Carlos Izpisua Belmonte one of TIME magazines 50 Most Influential People in Health Care for 2018 |
Salk Institute |
|
Tue, 10/16/2018 - 22:41 |
Avidity Biosciences Receives Investment from CureDuchenne |
CureDuchenne |
|
Tue, 10/16/2018 - 21:54 |
CureDuchenne Invests in ZappRx Platform to Develop Specialty Prescribing Application for Patients Suffering from Duchenne Muscular Dystrophy |
CureDuchenne |
